Overview

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
0
Participant gender:
Male
Summary
This study is to assess the effect of ASP1585 on pharmacokinetics of atorvastatin in 2x2 crossover method.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Atorvastatin
Atorvastatin Calcium
Criteria
Inclusion Criteria:

- Body weight: =<50.0kg, <80.0kg

- Body mass index: =<17.6, <26.4

- Healthy as judged by investigator or caregiver from subjective and objective symptoms
and physical examination data

Exclusion Criteria:

- Attending another clinical trial within 120 days before the study

- Blood donation within 90 days (400ml) or 30 days (200ml) before the study

- Receiving any drugs within 7 days before the study

- History of allergy to drugs

- Having GI disorders

- History or complication of liver diseases

- History or complication of heart disease

- History or complication of respiratory diseases

- History or complication of renal diseases

- History or complication of cerebrovascular diseases